{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Lea M"],"funding":["Diakonhjemmet Hospital","South-Eastern Norway Regional Health Authority","Oslo University Hospital","Hospital Pharmacies Enterprise, South Eastern Norway"],"pagination":["e041558"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7778779"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(12)"],"pubmed_abstract":["<h4>Objective</h4>To investigate the effect of pharmacist-led medicines management in multimorbid, hospitalised patients on long-term hospital readmissions and survival.<h4>Design</h4>Parallel-group, randomised controlled trial.<h4>Setting</h4>Recruitment from an internal medicine hospital ward in Oslo, Norway. Patients were enrolled consecutively from August 2014 to the predetermined target number of 400 patients. The last participant was enrolled March 2016. Follow-up until 31 December 2017, that is, 21-40 months.<h4>Participants</h4>Acutely admitted multimorbid patients ≥18 years, using minimum four regular drugs from minimum two therapeutic classes. 399 patients were randomly assigned, 1:1, to the intervention or control group. After excluding 11 patients dying in-hospital and 2 errone"],"journal":["BMJ open"],"pubmed_title":["Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial."],"pmcid":["PMC7778779"],"funding_grant_id":["12/00718"],"pubmed_authors":["Molden E","Mathiesen L","Mowe M","Kvernrod K","Skovlund E","Lea M"],"additional_accession":[]},"is_claimable":false,"name":"Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial.","description":"<h4>Objective</h4>To investigate the effect of pharmacist-led medicines management in multimorbid, hospitalised patients on long-term hospital readmissions and survival.<h4>Design</h4>Parallel-group, randomised controlled trial.<h4>Setting</h4>Recruitment from an internal medicine hospital ward in Oslo, Norway. Patients were enrolled consecutively from August 2014 to the predetermined target number of 400 patients. The last participant was enrolled March 2016. Follow-up until 31 December 2017, that is, 21-40 months.<h4>Participants</h4>Acutely admitted multimorbid patients ≥18 years, using minimum four regular drugs from minimum two therapeutic classes. 399 patients were randomly assigned, 1:1, to the intervention or control group. After excluding 11 patients dying in-hospital and 2 errone","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2026-05-05T05:27:35.215Z","creation":"2021-02-20T21:36:13Z"},"accession":"S-EPMC7778779","cross_references":{"pubmed":["33376173"],"doi":["10.1136/bmjopen-2020-041558"]}}